{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:14:44Z","timestamp":1788221684363,"version":"build-2803163510"},"reference-count":162,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Mitochondria are central regulators of breast cancer progression and therapy response, acting beyond energy metabolism to integrate redox balance, regulated cell death, metabolic plasticity, and immune signaling. This review summarizes how mitochondrial metabolism, dynamics, stress signaling, and quality-control pathways shape tumor heterogeneity, immune evasion, and treatment outcomes across tumor, immune, and stromal compartments. In breast cancer, subtype-specific mitochondrial programs influence oxidative phosphorylation, fatty acid oxidation, glutaminolysis, lactate accumulation, and mtDAMP signaling, thereby contributing to immune suppression and therapeutic resistance. We further discuss how mitochondrial regulation of apoptosis, ferroptosis, cuproptosis, and pyroptosis reveals both therapeutic opportunities and unresolved limitations. Although mitochondria-targeted strategies show translational promise, their clinical application remains constrained by metabolic heterogeneity, adaptive rewiring, immune-cell liability, and insufficient biomarkers. Overall, mitochondria represent a context-dependent therapeutic axis in breast cancer.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1715998","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:51:23Z","timestamp":1776837083000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Mitochondrial biology and immune crosstalk in breast cancer: therapeutic opportunities and challenges"],"prefix":"10.3389","volume":"17","author":[{"given":"Yulin","family":"Zeng","sequence":"first","affiliation":[{"name":"School of Basic Medical Sciences, Lanzhou University","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Guo","sequence":"additional","affiliation":[{"name":"Arc Institute","place":["Palo Alto, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17071102","article-title":"Molecular subtypes and mechanisms of breast cancer: precision medicine approaches for targeted therapies","volume":"17","author":"Carvalho","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/jbi\/wbaa110","article-title":"Molecular subtypes of breast cancer: a review for breast radiologists","volume":"3","author":"Johnson","year":"2021","journal-title":"J Breast Imaging"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/cells8050401","article-title":"Mitochondrial flexibility of breast cancers: a growth advantage and a therapeutic opportunity","volume":"8","author":"Avagliano","year":"2019","journal-title":"Cells"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.01.002","article-title":"Aggressive triple negative breast cancers have unique molecular signature on the basis of mitochondrial genetic and functional defects","volume":"1864","author":"Guha","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"13748","DOI":"10.1038\/s41598-019-50141-z","article-title":"Role of mitochondria in rescuing glycolytically inhibited subpopulation of triple negative but not hormone-responsive breast cancer cells","volume":"9","author":"Reda","year":"2019","journal-title":"Sci Rep"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.1038\/s41467-023-40022-5","article-title":"Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers","volume":"14","author":"El-Botty","year":"2023","journal-title":"Nat Commun"},{"key":"B8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.20892\/j.issn.2095-3941.2019.0210","article-title":"Metabolic reprogramming in triple-negative breast cancer","volume":"17","author":"Wang","year":"2020","journal-title":"Cancer Biol Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-20-3242","article-title":"Oxidative phosphorylation is a metabolic vulnerability in chemotherapy-resistant triple-negative breast cancer","volume":"81","author":"Evans","year":"2021","journal-title":"Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1101\/2025.08.21.671546","article-title":"Quiescent OXPHOS-high triple-negative breast cancer cells that persist after chemotherapy depend on BCL-XL for survival","volume":"14","author":"Andrzejewski","year":"2025","journal-title":"Cells"},{"key":"B11","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/febs.14756","article-title":"Metabolic reprogramming in breast cancer results in distinct mitochondrial bioenergetics between luminal and basal subtypes","volume":"286","author":"Lunetti","year":"2019","journal-title":"FEBS J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/biom12030379","article-title":"Characterization of mitochondrial proteome and function in luminal A and basal-like breast cancer subtypes reveals alteration in mitochondrial dynamics and bioenergetics relevant to their diagnosis","volume":"12","author":"Ortega-Lozano","year":"2022","journal-title":"Biomolecules"},{"key":"B13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12964-023-01178-1","article-title":"The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape","volume":"21","author":"Zipinotti Dos Santos","year":"2023","journal-title":"Cell Commun Signal"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1530\/erc-12-0398","article-title":"Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer","volume":"20","author":"Kim","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2015.02.004","article-title":"Cross-talk between ER and HER2 regulates c-MYC-mediated glutamine metabolism in aromatase inhibitor resistant breast cancer cells","volume":"149","author":"Chen","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1381970","article-title":"Targeting metabolism of breast cancer and its implications in T cell immunotherapy","volume":"15","author":"Zou","year":"2024","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2018.04.022","article-title":"Aerobic glycolysis controls myeloid-derived suppressor cells and tumor immunity via a specific CEBPB isoform in triple-negative breast cancer","volume":"28","author":"Li","year":"2018","journal-title":"Cell Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.598626","article-title":"Lactate metabolism and immune modulation in breast cancer: a focused review on triple negative breast tumors","volume":"10","author":"Naik","year":"2020","journal-title":"Front Oncol"},{"key":"B19","article-title":"Accelerated glycolysis in tumor microenvironment is associated with worse survival in triple-negative but not consistently with ER+\/HER2- breast cancer","volume":"13","author":"Oshi","year":"2023","journal-title":"Am J Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24433","article-title":"Metabolic profiles of triple-negative and luminal A breast cancer subtypes in African-American identify key metabolic differences","volume":"9","author":"Tayyari","year":"2018","journal-title":"Oncotarget"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1416472","article-title":"Glycolysis in the tumor microenvironment: a driver of cancer progression and a promising therapeutic target","volume":"12","author":"Zhao","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aax4585","article-title":"Breast cancer-associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells","volume":"13","author":"G\u00f3mez","year":"2020","journal-title":"Sci Signal"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-025-01627-8","article-title":"ADSL-generated fumarate binds and inhibits STING to promote tumour immune evasion","volume":"27","author":"Duan","year":"2025","journal-title":"Nat Cell Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1172\/jci140100","article-title":"Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer","volume":"131","author":"Edwards","year":"2021","journal-title":"J Clin Invest"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202510224","article-title":"PLA2G16-mediated tetracosatetraenoic acid rewires fatty acid oxidation to impair CD8(+) T cell immune function in promoting breast cancer lung metastasis","volume":"13","author":"Gan","year":"2026","journal-title":"Adv Sci (Weinh)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"6587","DOI":"10.1038\/s41467-024-50998-3","article-title":"Targeting fatty acid oxidation enhances response to HER2-targeted therapy","volume":"15","author":"Nandi","year":"2024","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114282","article-title":"Therapeutic potential of targeting mitochondrial dynamics in cancer","volume":"182","author":"Rodrigues","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1042\/bst20230220","article-title":"Recent insights into the control of mitochondrial fission","volume":"52","author":"He","year":"2024","journal-title":"Biochem Soc Trans"},{"key":"B29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00401-011-0930-z","article-title":"Less than perfect divorces: dysregulated mitochondrial fission and neurodegeneration","volume":"123","author":"Oettinghaus","year":"2012","journal-title":"Acta Neuropathol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.263847","article-title":"Mitochondrial dynamics and signaling in stem cell differentiation","volume":"139","author":"Verma","year":"2026","journal-title":"J Cell Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.494","article-title":"Mitochondrial dynamics regulates migration and invasion of breast cancer cells","volume":"32","author":"Zhao","year":"2013","journal-title":"Oncogene"},{"key":"B32","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1080\/14796694.2024.2447813","article-title":"DRP1: shedding light on the complex nexus of mitochondrial fission and breast cancer","volume":"21","author":"You","year":"2025","journal-title":"Future Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106788","article-title":"Enhanced mitochondrial fission inhibits triple-negative breast cancer cell migration through an ROS-dependent mechanism","volume":"26","author":"Humphries","year":"2023","journal-title":"iScience"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2012.07.012","article-title":"Mitochondrial dynamics is affected by 17\u03b2-estradiol in the MCF-7 breast cancer cell line. Effects on fusion and fission related genes","volume":"44","author":"Sastre-Serra","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.873834","article-title":"Impact of Drp1-mediated mitochondrial dynamics on T cell immune modulation","volume":"13","author":"Song","year":"2022","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.7150\/jca.96100","article-title":"Spatial and single-cell investigations illuminate theragnostic value and immune landscape of mitochondrial dynamin-like GTPase in breast cancer","volume":"15","author":"Tzeng","year":"2024","journal-title":"J Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.01.075","article-title":"Engineering nanoparticles boost TNBC therapy by CD24 blockade and mitochondrial dynamics regulation","volume":"355","author":"Zhao","year":"2023","journal-title":"J Control Release"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-20-1723","article-title":"Hedgehog signaling regulates metabolism and polarization of mammary tumor-associated macrophages","volume":"81","author":"Hinshaw","year":"2021","journal-title":"Cancer Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157400","article-title":"Mitochondrial metabolism in T-cell exhaustion","volume":"26","author":"Li","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s10238-025-01888-5","article-title":"Exploring the prognostic value of T cell exhaustion and mitochondrial dysfunction related genes in breast cancer through bioinformatics analysis and RT-qPCR validation","volume":"25","author":"Wan","year":"2025","journal-title":"Clin Exp Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116526","article-title":"Cancer-associated adipocytes mediate CD8(+)T cell dysfunction via FGF21-driven lipolysis","volume":"44","author":"Dalangood","year":"2025","journal-title":"Cell Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70192","article-title":"From mitochondria to immunity: the emerging roles of mitochondria-derived vesicles and small extracellular vesicles in cellular communication and disease","volume":"14","author":"Horbay","year":"2025","journal-title":"J Extracell Vesicles"},{"key":"B43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13045-022-01317-0","article-title":"The mitochondrial unfolded protein response (UPR(mt)): shielding against toxicity to mitochondria in cancer","volume":"15","author":"Inigo","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-022-00766-z","article-title":"Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria","volume":"33","author":"Xie","year":"2023","journal-title":"Cell Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512511","article-title":"ATAD3A: a key regulator of mitochondria-associated diseases","volume":"24","author":"Chen","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0365-3","article-title":"Enforced PGC-1\u03b1 expression promotes CD8 T cell fitness, memory formation and antitumor immunity","volume":"18","author":"Dumauthioz","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/ncb3039","article-title":"PGC-1\u03b1 mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis","volume":"16","author":"LeBleu","year":"2014","journal-title":"Nat Cell Biol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10549-020-05729-9","article-title":"Activation of mitochondrial unfolded protein response is associated with Her2-overexpression breast cancer","volume":"183","author":"Chen","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1199152","article-title":"Targeting the stimulator of interferon genes (STING) in breast cancer","volume":"14","author":"Ying-Rui","year":"2023","journal-title":"Front Pharmacol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1619097","article-title":"Dual regulation of the cGAS-STING pathway: new targets and challenges for subtype-specific immunotherapy in breast cancer","volume":"15","author":"Xiong","year":"2025","journal-title":"Front Oncol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","article-title":"Mitochondria as multifaceted regulators of cell death","volume":"21","author":"Bock","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a008706","article-title":"Mitochondrial regulation of cell death","volume":"5","author":"Tait","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2792","article-title":"Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance","volume":"6","author":"Williams","year":"2015","journal-title":"Oncotarget"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5303.1129","article-title":"Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked","volume":"275","author":"Yang","year":"1997","journal-title":"Science"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.038166","article-title":"Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis","volume":"122","author":"Dewson","year":"2009","journal-title":"J Cell Sci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"111304","DOI":"10.2139\/ssrn.3730213","article-title":"BET inhibition induces vulnerability to MCL1 targeting through upregulation of fatty acid synthesis pathway in breast cancer","volume":"40","author":"Yan","year":"2022","journal-title":"Cell Rep"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2022.2054096","article-title":"MCL-1 is a clinically targetable vulnerability in breast cancer","volume":"21","author":"Winder","year":"2022","journal-title":"Cell Cycle"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-021-00773-4","article-title":"Breast cancer dependence on MCL-1 is due to its canonical anti-apoptotic function","volume":"28","author":"Campbell","year":"2021","journal-title":"Cell Death Differ"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1159\/000525281","article-title":"PARP inhibition and beyond in BRCA-associated breast cancer in women: a state-of-the-art summary of preclinical research on risk reduction and clinical benefits","volume":"31","author":"Pauwels","year":"2022","journal-title":"Med Princ Pract"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2004.36.4.214","article-title":"DNA damage response mediated through BRCA1","volume":"36","author":"Jang","year":"2004","journal-title":"Cancer Res Treat"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4048\/jbc.2021.24.e39","article-title":"BRCA1 reversion mutation confers resistance to olaparib and camrelizumab in a patient with breast cancer liver metastasis","volume":"24","author":"Pan","year":"2021","journal-title":"J Breast Cancer"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15143642","article-title":"Mechanisms of PARP-inhibitor-resistance in BRCA-mutated breast cancer and new therapeutic approaches","volume":"15","author":"Dilmac","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2025.101034","article-title":"Multi-omics characterization of acquired olaparib resistance in BRCA1 and BRCA2 mutant breast cancer cell lines","volume":"24","author":"Anagho-Mattanovich","year":"2025","journal-title":"Mol Cell Proteomics"},{"key":"B64","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cellsig.2009.09.034","article-title":"Differential modulation of BRCA1 and BARD1 nuclear localisation and foci assembly by DNA damage","volume":"22","author":"Brodie","year":"2010","journal-title":"Cell Signal"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-007-0167-4","article-title":"Caspase-dependent BRCA1 cleavage facilitates chemotherapy-induced apoptosis","volume":"13","author":"Dizin","year":"2008","journal-title":"Apoptosis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m702627200","article-title":"BARD1 translocation to mitochondria correlates with Bax oligomerization, loss of mitochondrial membrane potential, and apoptosis","volume":"282","author":"Tembe","year":"2007","journal-title":"J Biol Chem"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.06.002","article-title":"Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancer","volume":"24","author":"Vaillant","year":"2013","journal-title":"Cancer Cell"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14020279","article-title":"Regulation of Bcl-2 family proteins in estrogen receptor-positive breast cancer and their implications in endocrine therapy","volume":"14","author":"Kawiak","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-21-3811","article-title":"VERONICA: Randomized phase II study of fulvestrant and venetoclax in ER-positive metastatic breast cancer post-CDK4\/6 inhibitors - efficacy, safety, and biomarker results","volume":"28","author":"Lindeman","year":"2022","journal-title":"Clin Cancer Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.674192","article-title":"The immunology of hormone receptor positive breast cancer","volume":"12","author":"Goldberg","year":"2021","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17172940","article-title":"Unlocking the potential of immune checkpoint inhibitors in HR+\/HER2- breast cancer: a systematic review","volume":"17","author":"Di Grazia","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B72","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1158\/2159-8290.cd-19-0759","article-title":"Venetoclax increases intratumoral effector T cells and antitumor efficacy in combination with immune checkpoint blockade","volume":"11","author":"Kohlhapp","year":"2021","journal-title":"Cancer Discov"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262412171","article-title":"Immune checkpoint inhibitor therapy in hormone receptor-positive breast cancer","volume":"26","author":"Lin","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065564","article-title":"Promising strategy of mPTP modulation in cancer therapy: an emerging progress and future insight","volume":"24","author":"Waseem","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2014.00302","article-title":"The mitochondrial permeability transition pore and cancer: molecular mechanisms involved in cell death","volume":"4","author":"Bonora","year":"2014","journal-title":"Front Oncol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1499125","article-title":"Targeting ferroptosis: a promising strategy to overcome drug resistance in breast cancer","volume":"14","author":"Peng","year":"2024","journal-title":"Front Oncol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1284057","article-title":"Ferroptosis: the emerging player in remodeling triple-negative breast cancer","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2023.03.019","article-title":"Mitochondria-related signaling pathways involved in breast cancer regulate ferroptosis","volume":"11","author":"Dong","year":"2024","journal-title":"Genes Dis"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199686","article-title":"Metabolic regulation of ferroptosis in breast cancer","volume":"26","author":"Glibetic","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B80","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41420-021-00473-5","article-title":"The role of ferroptosis in breast cancer patients: a comprehensive analysis","volume":"7","author":"Wu","year":"2021","journal-title":"Cell Death Discov"},{"key":"B81","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","article-title":"Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy","volume":"35","author":"Yang","year":"2023","journal-title":"Cell Metab"},{"key":"B82","article-title":"Ferroptosis: a promising target for cancer immunotherapy","volume":"11","author":"Sun","year":"2021","journal-title":"Am J Cancer Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.17419","article-title":"Bioinformatic analysis and experimental validation of six cuproptosis-associated genes as a prognostic signature of breast cancer","volume":"12","author":"Chen","year":"2024","journal-title":"PeerJ"},{"key":"B84","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12935-024-03572-2","article-title":"Cuproptosis: a promising new target for breast cancer therapy","volume":"24","author":"Jiang","year":"2024","journal-title":"Cancer Cell Int"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"key":"B86","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41392-022-01014-x","article-title":"Cuproptosis: lipoylated TCA cycle proteins-mediated novel cell death pathway","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0299138","article-title":"Cuproptosis-associated ncRNAs predict breast cancer subtypes","volume":"19","author":"Xia","year":"2024","journal-title":"PLoS One"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.963639","article-title":"Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas","volume":"10","author":"Huang","year":"2023","journal-title":"Front Mol Biosci"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1039\/d3tb02886k","article-title":"A mitochondria-targeted anticancer copper dithiocarbamate amplifies immunogenic cuproptosis and macrophage polarization","volume":"12","author":"Lu","year":"2024","journal-title":"J Mater Chem B"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1344023","article-title":"Comprehending the cuproptosis and cancer-immunity cycle network: delving into the immune landscape and its predictive role in breast cancer immunotherapy responses and clinical endpoints","volume":"15","author":"Liu","year":"2024","journal-title":"Front Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"10060","DOI":"10.1038\/s41467-024-54469-7","article-title":"Regulating copper homeostasis of tumor cells to promote cuproptosis for enhancing breast cancer immunotherapy","volume":"15","author":"Guan","year":"2024","journal-title":"Nat Commun"},{"key":"B92","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s12964-024-01932-z","article-title":"The role of pyroptosis in cancer: key components and therapeutic potential","volume":"22","author":"Liu","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.01.009","article-title":"Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis","volume":"36","author":"Shimada","year":"2012","journal-title":"Immunity"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1378990","article-title":"ROS induced pyroptosis in inflammatory disease and cancer","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41420-023-01370-9","article-title":"Targeting pyroptosis in breast cancer: biological functions and therapeutic potentials on it","volume":"9","author":"Chen","year":"2023","journal-title":"Cell Death Discov"},{"key":"B96","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12929-021-00724-8","article-title":"NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer","volume":"28","author":"Faria","year":"2021","journal-title":"J BioMed Sci"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1446486","article-title":"Dual roles of inflammatory programmed cell death in cancer: insights into pyroptosis and necroptosis","volume":"15","author":"Wang","year":"2024","journal-title":"Front Pharmacol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00262-024-03752-z","article-title":"GSDME-mediated pyroptosis promotes anti-tumor immunity of neoadjuvant chemotherapy in breast cancer","volume":"73","author":"Fu","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2023.08.011","article-title":"Tumor microenvironmental nutrients, cellular responses, and cancer","volume":"30","author":"Lobel","year":"2023","journal-title":"Cell Chem Biol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218363","article-title":"Lactic acid and an acidic tumor microenvironment suppress anticancer immunity","volume":"21","author":"Wang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.4110\/in.2025.25.e30","article-title":"Arginine metabolism in cancer biology and immunotherapy","volume":"25","author":"Bai","year":"2025","journal-title":"Immune Netw"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.932055","article-title":"Lactate from the tumor microenvironment - a key obstacle in NK cell-based immunotherapies","volume":"13","author":"Jedli\u010dka","year":"2022","journal-title":"Front Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"789","DOI":"10.20892\/j.issn.2095-3941.2025.0173","article-title":"Lactate and lactylation in breast cancer: current understanding and therapeutic opportunities","volume":"22","author":"Huang","year":"2025","journal-title":"Cancer Biol Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.979154","article-title":"Tumor acidity: from hallmark of cancer to target of treatment","volume":"12","author":"Bogdanov","year":"2022","journal-title":"Front Oncol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2023.102970","article-title":"Tumor interstitial fluid analysis enables the study of microenvironment-cell interactions in cancers","volume":"83","author":"Apiz Saab","year":"2023","journal-title":"Curr Opin Biotechnol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00832","article-title":"Mitochondrial damage-associated molecular patterns: from inflammatory signaling to human diseases","volume":"9","author":"Grazioli","year":"2018","journal-title":"Front Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228877","article-title":"The impact of radiation-induced DNA damage on cGAS-STING-mediated immune responses to cancer","volume":"21","author":"Storozynsky","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B108","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12943-025-02380-0","article-title":"Demystifying the cGAS-STING pathway: precision regulation in the tumor immune microenvironment","volume":"24","author":"Wang","year":"2025","journal-title":"Mol Cancer"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052495","article-title":"P2X7 receptor in dendritic cells and macrophages: implications in antigen presentation and T lymphocyte activation","volume":"25","author":"Acu\u00f1a-Castillo","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00793","article-title":"P2X7 in cancer: from molecular mechanisms to therapeutics","volume":"11","author":"Lara","year":"2020","journal-title":"Front Pharmacol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00760-x","article-title":"Mitochondrial control\u00a0of inflammation","volume":"23","author":"Marchi","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-022-06633-0","article-title":"Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer","volume":"194","author":"Oshi","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110710","article-title":"The mitochondrial stress signaling tunes immunity from a view of systemic tumor microenvironment and ecosystem","volume":"27","author":"Kuo","year":"2024","journal-title":"iScience"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17111958","article-title":"Pro-tumoral inflammatory myeloid cells as emerging therapeutic targets","volume":"17","author":"Szebeni","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3892\/or.2021.7946","article-title":"Metabolic heterogeneity and immunocompetence of infiltrating immune cells in the breast cancer microenvironment (review)","volume":"45","author":"Chen","year":"2021","journal-title":"Oncol Rep"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1506849","article-title":"Crosstalk between lactate and tumor-associated immune cells: clinical relevance and insight","volume":"14","author":"Sun","year":"2024","journal-title":"Front Oncol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s13287-021-02377-8","article-title":"Optimising NK cell metabolism to increase the efficacy of cancer immunotherapy","volume":"12","author":"Choi","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"B118","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/itt.s492334","article-title":"Adaptation of natural killer cells to hypoxia: a review of the transcriptional, translational, and metabolic processes","volume":"14","author":"Chang","year":"2025","journal-title":"Immunotargets Ther"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.108803","article-title":"Unraveling the breast cancer tumor microenvironment: crucial factors influencing natural killer cell function and therapeutic strategies","volume":"21","author":"Li","year":"2025","journal-title":"Int J Biol Sci"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.613492","article-title":"Metabolism of dendritic cells in tumor microenvironment: for immunotherapy","volume":"12","author":"Peng","year":"2021","journal-title":"Front Immunol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012127","article-title":"Myeloid metabolism and its role in immunotherapy of cancer","volume":"13","author":"Garlatti","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1172\/jci175445","article-title":"Modulation of macrophage metabolism as an emerging immunotherapy strategy for cancer","volume":"134","author":"Dussold","year":"2024","journal-title":"J Clin Invest"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6075403","article-title":"Metabolic reprogramming of cancer associated fibroblasts: the slavery of stromal fibroblasts","volume":"2018","author":"Avagliano","year":"2018","journal-title":"BioMed Res Int"},{"key":"B124","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s13046-022-02524-w","article-title":"The importance of being CAFs (in cancer resistance to targeted therapies)","volume":"41","author":"Rizzolio","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.32604\/or.2025.065953","article-title":"Hypoxic link between cancer cells and the immune system: the role of adenosine and lactate","volume":"33","author":"Alvarado-Ortiz","year":"2025","journal-title":"Oncol Res"},{"key":"B126","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13046-024-03101-z","article-title":"Shikonin blocks CAF-induced TNBC metastasis by suppressing mitochondrial biogenesis through GSK-3\u03b2\/NEDD4\u20131 mediated phosphorylation-dependent degradation of PGC-1\u03b1","volume":"43","author":"Fan","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B127","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40364-026-00902-6","article-title":"Mitochondrial DNA mutations and intercellular mitochondrial transfer in cancer: mechanisms, biological effects, and clinical potential","volume":"14","author":"Chen","year":"2026","journal-title":"biomark Res"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1749965","article-title":"Targeting MDSCs in cancer: emerging immunotherapeutic and metabolic strategies","volume":"17","author":"Dash","year":"2026","journal-title":"Front Immunol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.260419","article-title":"Mitochondrial transfer from cancer-associated fibroblasts increases migration in aggressive breast cancer","volume":"136","author":"Goliwas","year":"2023","journal-title":"J Cell Sci"},{"key":"B130","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12943-024-02165-x","article-title":"Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer","volume":"23","author":"Liu","year":"2024","journal-title":"Mol Cancer"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol33020129","article-title":"Metabolic vulnerabilities as a therapeutic target in breast cancer","volume":"33","author":"Guo","year":"2026","journal-title":"Curr Oncol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13583","article-title":"Targeting cancer and immune cell metabolism with the complex I inhibitors metformin and IACS-010759","volume":"18","author":"Pujalte-Martin","year":"2024","journal-title":"Mol Oncol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02103-8","article-title":"Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials","volume":"29","author":"Yap","year":"2023","journal-title":"Nat Med"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005719","article-title":"Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression","volume":"11","author":"Finisguerra","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B135","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.molcel.2018.07.030","article-title":"Metformin promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1","volume":"71","author":"Cha","year":"2018","journal-title":"Mol Cell"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713353","article-title":"The impact of metformin on tumor-infiltrated immune cells: preclinical and clinical studies","volume":"24","author":"Abdelmoneim","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-023-00777-4","article-title":"Mitochondrial PD-L1 modulates cancer immunotherapy","volume":"33","author":"Dai","year":"2023","journal-title":"Cell Res"},{"key":"B138","doi-asserted-by":"publisher","first-page":"5685","DOI":"10.1038\/s41467-022-33301-0","article-title":"A protein-based cGAS-STING nanoagonist enhances T cell-mediated anti-tumor immune responses","volume":"13","author":"Wang","year":"2022","journal-title":"Nat Commun"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.123955","article-title":"Co-delivery of doxorubicin and STING agonist cGAMP for enhanced antitumor immunity","volume":"654","author":"Xie","year":"2024","journal-title":"Int J Pharm"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abn6612","article-title":"Selective STING stimulation in dendritic cells primes antitumor T cell responses","volume":"8","author":"Jneid","year":"2023","journal-title":"Sci Immunol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2022.12.023","article-title":"Nanodroplet-enhanced sonodynamic therapy potentiates immune checkpoint blockade for systemic suppression of triple-negative breast cancer","volume":"158","author":"Wu","year":"2023","journal-title":"Acta Biomater"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08439-0","article-title":"Immune evasion through mitochondrial transfer in the tumour microenvironment","volume":"638","author":"Ikeda","year":"2025","journal-title":"Nature"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-00834-9","article-title":"Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion","volume":"22","author":"Scharping","year":"2021","journal-title":"Nat Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0725-2","article-title":"Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen","volume":"21","author":"Vardhana","year":"2020","journal-title":"Nat Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010062","article-title":"The effect of oxidative phosphorylation on cancer drug resistance","volume":"15","author":"Zhao","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbiosy.2021.100023","article-title":"Mitochondria-targeted nanoparticles (mitoNANO): an emerging therapeutic shortcut for cancer","volume":"3","author":"Tabish","year":"2021","journal-title":"Biomater Biosyst"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3390\/nano12050743","article-title":"Recent advancements in mitochondria-targeted nanoparticle drug delivery for cancer therapy","volume":"12","author":"Xu","year":"2022","journal-title":"Nanomater (Basel)"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174435","article-title":"Recent advances in exosome-based drug delivery for cancer therapy","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B149","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41467-025-55905-y","article-title":"Engineered hypoxia-responsive albumin nanoparticles mediating mitophagy regulation for cancer therapy","volume":"16","author":"Wang","year":"2025","journal-title":"Nat Commun"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.7150\/thno.104190","article-title":"Hypoxia-responsive nanoparticles for fluorescence diagnosis and therapy of cancer","volume":"15","author":"Zhang","year":"2025","journal-title":"Theranostics"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.784602","article-title":"Mitochondria-targeted nanocarriers promote highly efficient cancer therapy: a review","volume":"9","author":"Zeng","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12951-024-02585-3","article-title":"Strategic disruption of cancer's powerhouse: precise nanomedicine targeting of mitochondrial metabolism","volume":"22","author":"Lin","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.2147\/cpaa.s526895","article-title":"Triphenylphosphine-based mitochondrial targeting nanocarriers: advancing cancer therapy","volume":"17","author":"Ali","year":"2025","journal-title":"Clin Pharmacol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40164-025-00689-6","article-title":"Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies","volume":"14","author":"Wang","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1089\/ars.2023.0379","article-title":"Therapeutic targeting of mitochondrial plasticity and redox control to overcome cancer chemoresistance","volume":"39","author":"Mani","year":"2023","journal-title":"Antioxid Redox Signal"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19612","article-title":"Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: early detection of treatment failure with companion diagnostics","volume":"8","author":"Sotgia","year":"2017","journal-title":"Oncotarget"},{"key":"B157","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1038\/s41598-024-52981-w","article-title":"Prognosis prediction and risk stratification of breast cancer patients based on a mitochondria-related gene signature","volume":"14","author":"Wang","year":"2024","journal-title":"Sci Rep"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1712089","article-title":"Development and validation of a machine learning-driven mitochondrial gene signature for the diagnosis of breast cancer","volume":"16","author":"Tong","year":"2025","journal-title":"Front Immunol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70897","article-title":"The roles of exosomes in anti-cancer drugs","volume":"14","author":"Feng","year":"2025","journal-title":"Cancer Med"},{"key":"B160","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41420-024-02226-6","article-title":"Mitophagy: insights into its signaling molecules, biological functions, and therapeutic potential in breast cancer","volume":"10","author":"Chen","year":"2024","journal-title":"Cell Death Discov"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1039\/d5ra03747f","article-title":"Bridging technology and medicine: artificial intelligence in targeted anticancer drug delivery","volume":"15","author":"Khorsandi","year":"2025","journal-title":"RSC Adv"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1186\/s12967-025-07308-2","article-title":"Exploiting artificial intelligence in precision oncology: an updated comprehensive review","volume":"23","author":"Goda","year":"2025","journal-title":"J Transl Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1715998\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:51:26Z","timestamp":1776837086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1715998\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":162,"alternative-id":["10.3389\/fimmu.2026.1715998"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1715998","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"article-number":"1715998"}}